Acquired uniparental disomy of 17p is associated with mutations of TP53 gene in patients with MDS and complex karyotypes.

被引：0
|
作者：
Svobodova, Karla [1 ,2 ]
Zemanova, Zuzana [1 ,2 ]
Lhotska, Halka [1 ,2 ]
Belickova, Monika [3 ]
Brezinova, Jana [4 ]
Sarova, Iveta [4 ]
Izakova, Silvia [1 ,2 ]
Lizcova, Libuse [1 ,2 ]
Ransdorfova, Sarka [4 ]
Berkova, Adela [1 ,2 ]
Siskova, Magda [1 ,5 ]
Jonasova, Anna [1 ,5 ]
Cermak, Jaroslav [6 ]
Michalova, Kyra [2 ]
机构：
[1] Gen Univ Hosp, Prague 2, Czech Republic
[2] Charles Univ Prague, Ctr Oncocytogenet, Inst Med Biochem & Lab Diagnost, Fac Med 1, Prague, Czech Republic
[3] Inst Hematol & Blood Transfus, Dept Mol Genet, Prague, Czech Republic
[4] Inst Hematol & Blood Transfus, Dept Cytogenet, Prague, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Med Dept 1, Prague, Czech Republic
[6] Inst Hematol & Blood Transfus, Clinal Dept, Prague, Czech Republic
来源：
CHROMOSOME RESEARCH | 2015年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2.P21
引用
收藏
页码：S85 / S86
页数：2
相关论文
共 50 条
  • [41] BIALLELIC TP53 GENE MUTATIONS DUE TO COPY-NEUTRAL LOSS OF HETEROZYGOSITY AND MONOALLELIC MUTATIONS IN ABSENCE OF 17P DELETION OCCUR IN CLL WITH COMPARABLE FREQUENCY
    Plevova, K.
    Malcikova, J.
    Pavlova, S.
    Kotaskova, J.
    Poppova, L.
    Smardova, J.
    Diviskova, E.
    Durechova, K.
    Oltova, A.
    Brychtova, Y.
    Panovska, A.
    Doubek, M.
    Pospisilova, S.
    HAEMATOLOGICA, 2017, 102 : 65 - 66
  • [42] Increasing copy number abnormalities and somatic mutations including TP53 worsen overall survival in 17p deleted CLL
    Yu, Lijian
    Kim, Haesook
    Kasar, Siddha
    Benien, Parul
    Du, Wei
    Hoang, Kevin
    Improgo, Reina
    Fernandes, Stacey
    Klitgaard, Josephine L.
    Lee, Charles
    Getz, Gad
    Setlur, Sunita R.
    Brown, Jennifer
    LEUKEMIA & LYMPHOMA, 2015, 56 : 122 - 122
  • [43] THE PROGNOSTIC SIGNIFICANCE OF TP53 MUTATIONS IN MDS PATIENTS WITH DEL(5Q)
    Belickova, M.
    Vesela, J.
    Jonasova, A.
    Planetova, B.
    Valka, J.
    Mikulenkova, D.
    Zemanova, Z.
    Brezinova, J.
    Michalova, K.
    Cermak, J.
    LEUKEMIA RESEARCH, 2015, 39 : S22 - S23
  • [44] Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network
    Rossi, Marianna
    Croci, Giorgio
    Boveri, Emanuela
    Gianelli, Umberto
    Ponzoni, Maurilio
    Giordano, Laura
    Ubezio, Marta
    Travaglino, Erica
    Morabito, Lucio
    Milanesi, Chiara
    Saba, Elena
    Borin, Lorenza
    Bernardi, Massimo
    Santini, Valeria
    Voso, Maria Teresa
    Fenu, Susanna
    Orazi, Attilio
    Santoro, Armando
    Bacigalupo, Andrea
    Rambaldi, Alessandro
    Della Porta, Matteo Giovanni
    BLOOD, 2017, 130
  • [45] INACTIVATION OF THE P53 GENE IN LEUKEMIAS AND MYELODYSPLASTIC SYNDROME (MDS) WITH 17P MONOSOMY
    PREUDHOMME, C
    VANRUMBEKE, M
    LAI, JL
    LEPELLEY, P
    WATTEL, E
    FENAUX, P
    LEUKEMIA, 1994, 8 (12) : 2241 - 2242
  • [46] Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome
    Ferrari, Anna
    Papayannidis, Cristina
    Baldazzi, Carmen
    Iacobucci, Ilaria
    Paolini, Stefania
    Padella, Antonella
    Guadagnuolo, Viviana
    Perricone, Margherita
    Robustelli, Valentina
    Venturi, Claudia
    Abbenante, Maria Chiara
    Parisi, Sarah
    Sartor, Chiara
    Volpato, Francesca
    Testoni, Nicoletta
    Simonetti, Giorgia
    Ottaviani, Emanuela
    Martinelli, Giovanni
    BLOOD, 2014, 124 (21)
  • [47] Aberrant Nuclear p53 Expression Predicts Hemizygous 17p (TP53) Deletion in Chronic Lymphocytic Leukemia
    Chang, Hong
    Jiang, Allan M.
    Qi, Connie X. Y.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (01) : 70 - 74
  • [48] The Prognostic Significance of TP53 Mutations for Overall Outcome in Lower-Risk MDS Patients
    Belickova, Monika
    Vesela, Jitka
    Jonasova, Anna
    Stara, Eliska
    Planetova, Barbora
    Zemanova, Zuzana
    Brezinova, Jana
    Mikulenkova, Dana
    Cermak, Jaroslav
    BLOOD, 2014, 124 (21)
  • [49] Gene Amplifications Are Rare Events in AML and MDS and Are Associated with Complex Karyotype, TP53 Deletions and Very Poor Survival
    Haferlach, Claudia
    Grossmann, Vera
    Zenger, Melanie
    Kohlmann, Alexander
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Torsten
    BLOOD, 2011, 118 (21) : 1082 - 1082
  • [50] TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes
    Lazarian, Gregory
    Tausch, Eugen
    Eclache, Virginie
    Sebaa, Amel
    Bianchi, Vincent
    Letestu, Remi
    Collon, Jean-Francois
    Lefebvre, Valerie
    Gardano, Laura
    Varin-Blank, Nadine
    Soussi, Thierry
    Stilgenbauer, Stephen
    Cymbalista, Florence
    Baran-Marszak, Fanny
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (08) : 1759 - 1763
12345